Seagen veteran-led ProfoundBio gets $55M to bring cancer drugs to the clinic July 12, 2021 Auto Bot antibody-drug conjugate, BioPharma, biopharma nl, cancer, China, deals, investing, Pharma, Startups 0 ProfoundBio is developing a type of targeted cancer therapy called antibody drug conjugates. As the biotech looks ahead to clinical trials, it has raised more than $55 million in Series A funding.